LEADER 05239nam 2200793z- 450 001 9910899900003321 005 20240131152553.0 010 $a0-323-47785-2 035 $a(CKB)4100000005464037 035 $a(OCoLC)1050449004 035 $a(EXLCZ)994100000005464037 100 $a20180812h20182019 fy- 0 101 0 $aeng 181 $ctxt$2rdacontent 181 $csti$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aConsultative Hemostasis and Thrombosis /$fEditors, Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle, David A. Garcia 205 $aFourth ed. 210 1$aPhiladelphia, PA :$cElsevier,$d2018,©2019 215 $a1 online resource (xvi, 869 pages $ccolor illustrations 225 1 $aClinicalKey 300 $aRevised edition of: Consultative hemostasis and thrombosis / Editors, Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle. 3rd ed. ©2013. 311 $a0-323-46202-2 320 $aIncludes bibliographical references 327 $aPart 1: Hemorrhagic processes. Consultative process -- An approach to the bleeding patient: correlation of clinical symptoms and signs with laboratory testing -- Hemophilia A and B -- Less common congenital disorders of hemostasis -- Acquired coagulation disorders due to inhibitors -- von Willebrand disease -- General aspects of thrombocytopenia, platelet transfusions, and thrombopoietic growth factors -- Primary immune thrombocytopenia -- Congenital and acquired disorders of platelet function and number -- Purpura and other hematovascular disorders -- HHT -- Disseminated intravascular coagulation -- The cross-talk of inflammation and coagulation in infectious disease and their roles in disseminated intravascular coagulation -- Part 2: Thrombotic processes. Thrombophilia: clinical and laboratory assessment and management -- Pediatric aspects of thrombophilia -- Deep vein thrombosis, pulmonary embolism and primary pulmonary hypertension -- Venous thromboses at unusual sites -- The post thrombotic syndrome -- Thrombocytosis: essential thrombocytemia and reactive causes -- Antiphospholipid syndrome -- Antiplatelet treatment in cardiovascular medicine -- Non-arteriosclerotic arterial occlusive disease -- Thrombosis and cancer -- Thrombotic thrombocytopenic purpura -- Hemostatic disorders of complement activation (PNH and aHUS) -- Heparin-induced thrombocytopenia -- Part 3: Therapeutic agents. Antithrombotic agents -- Blood component and pharmacological agents -- Therapeutic apheresis: applications for hemorrhagic & thrombotic disorders -- Vena caval filters -- Part 4: Issues specific to women. Thrombotic risk of contraceptives and other hormonal therapies -- Bleeding and the management of hemorrhagic disorders in pregnancy -- Thrombophilia in pregnancy -- Part 5: Special issues. Surgery and hemostasis -- Anticoagulation in the perioperative period -- Understanding and managing the coagulopathy of liver disease -- Outpatient anticoagulant therapy -- Hematologic interventions for acute central nervous system disease -- Pending: atrial septal abnormalities and cryptogenic stroke -- Hemorrhage control and thrombosis following severe injury -- Hemostatic aspects of sickle cell disease 330 $a"With authoritative coverage of rare and common hemostatic disorders, Consultative Hemostasis and Thrombosis, 4th Edition, keeps you both up to date with all that's new in this fast-moving field as well as reviewing background and development and citing pertinent classical literature. Broad differential diagnoses are provided, underscoring the editors' position that correct treatment begins with correct diagnosis"--Publisher's description. 410 0$aClinicalKey. 606 $aBlood coagulation disorders 606 $aAnticoagulants (Medicine) 606 $aBlood platelet disorders 606 $aFibrinolytic agents 606 $aHemostasis$xPhysiological aspects 606 $aThrombosis$xPathophysiology 606 $aBlood Coagulation Disorders 606 $aThrombosis$xpathology 606 $aBlood Platelet Disorders 606 $aHemostasis$xphysiology 606 $aFibrinolytic Agents$xtherapeutic use 606 $aAnticoagulants$xtherapeutic use 615 0$aBlood coagulation disorders. 615 0$aAnticoagulants (Medicine) 615 0$aBlood platelet disorders. 615 0$aFibrinolytic agents. 615 0$aHemostasis$xPhysiological aspects. 615 0$aThrombosis$xPathophysiology. 615 12$aBlood Coagulation Disorders. 615 22$aThrombosis$xpathology. 615 22$aBlood Platelet Disorders. 615 22$aHemostasis$xphysiology. 615 22$aFibrinolytic Agents$xtherapeutic use. 615 22$aAnticoagulants$xtherapeutic use. 702 $aKitchens$b Craig S. 702 $aKessler$b Craig M. 702 $aKonkle$b Barbara A. 702 $aGarcia$b David A$g(David Allen), 801 0$bMMU 801 1$bMMU 801 2$bMMU 801 2$bOCLCO 801 2$bINM 801 2$bNLE 801 2$bOPELS 801 2$bUAB 801 2$bOPELS 906 $aBOOK 912 $a9910899900003321 996 $aConsultative Hemostasis and Thrombosis$94214008 997 $aUNINA